WILSON DISEASE
WEBINAR:
MAR 19, 2026
6:00pm to 7:00pm PDT
Do you know about Wilson Disease, a rare liver condition? Wilson disease is an inherited disorder that causes copper to build up in the liver, brain, and other organs. Liver-related symptoms include vomiting, weakness, fluid build-up in the abdomen, swelling of the legs, yellow skin and itchiness. Brain-related symptoms include tremors, muscle stiffness, trouble in speaking, personality changes, anxiety, and psychosis.
​
While copper plays a vital role in the healthy development of nerves and bones, too much copper is toxic. Most people with the condition are born with it, but symptoms often don't appear until later in life.
​
​To learn more about this complicated rare disease and have your questions answered, please register to join us.
TRANSITION OF CARE
WEBINAR:
MAY 23, 2026
6:00pm to 7:00pm PDT
You are cordially invited to join us for a free educational webinar on “Transition of Care.” During this webinar we will address the difficulties and details of Transferring liver patients’ care from pediatrics to adulthood as they grow up and life situations change. This is particularly important for those pediatric liver patients who are, or will be, in the process of moving to other States to continue their college education.
Transition of Care is a subject that we hardly hear about but is one of the most important turning points in the lives of thousands of young liver patients.
Please join us as we focus on this issue and dig deep to bring clarity and much needed information and help to all.
Metabolic Dysfunction- Associated Steatohepatitis (MASH)
WEBINAR:
JUN 18, 2026
6:00pm to 7:00pm PDT
In recognition of Fatty Liver Disease Day (June 11th), Liver Health Foundation is hosting an educational webinar on MASH or Metabolic Dysfunction-Associated Steatohepatitis on June 19th, to shed more light on this global epidemic and discuss the newest treatment options for this disease.
​
MASH is a serious liver disease characterized by the buildup of fat in the liver (steatosis), leading to inflammation and liver cell damage. It is part of a broader condition called metabolic dysfunction-associated steatotic liver disease (MASLD), which occurs in people who do not consume significant amounts of alcohol. The condition is strongly linked to metabolic issues such as obesity, insulin resistance, type 2 diabetes, high blood pressure, and abnormal cholesterol levels. Without treatment, MASH can progress to liver fibrosis, cirrhosis, liver failure, or liver cancer, requiring liver transplant.​
​
We invite you to join this free educational webinar and learn how to protect your liver and your life. During the webinar our expert hepatologists will respond to your questions.
LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)
WEBINAR:
JUL 16, 2026
6:00pm to 7:00pm PDT
You are kindly invited to attend an educational webinar on Lysosomal Acid Lipase deficiency (LAL-D), characterized by the body’s inability to properly break down and utilize certain fats. When fats are not broken down and used, they accumulate in many of the body’s cells, tissues and organs and eventually lead to signs of liver disease. There are two types of LAL-D.
​
-
Infantile LAL-D is present early in infancy and is less common and more severe than late-onset LAL-D. Children with infantile-onset LAL-D generally begin exhibiting signs of the disease shortly after birth as fat molecules begin to accumulate throughout the body.
-
Late-onset LAL-D is generally present in mid-childhood. Children with late-onset LAL-D show great variation in their symptoms and the age at which signs of the disease begin to show. While many have their first symptoms in mid-childhood, some first develop symptoms in adolescence or even adulthood.
Please join us to learn more about LAL-D, on July 26, 2026. Our expert speakers will discuss this disease and will respond to your questions.
WHAT IS HEPATORENAL SYNDROME (HRS)?
WEBINAR:
May 22, 2025
6:00pm to 7:00pm PDT
Hepatorenal Syndrome is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis, ascites, portal hypertension, or sudden liver failure. HRS may be fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent advancement of the condition. The only certain way to prevent HRS is to keep your liver healthy.
To reduce your risk of developing Hepatorenal Syndrome, please avoid excessive drinking and stay on a healthy diet for your liver. To learn more about HRS join us Thursday, May 22nd, for an Indepth presentation by our expert, Dr. Robert Gish.
RARE LIVER DISEASE
BILIARY ATRESIA
WEBINAR:
JUL 17, 2025
5:30pm to 6:30pm PDT
Biliary atresia is a rare congenital liver disease that affects infants, characterized by the scarred and blocked bile ducts inside and outside the liver. The bile ducts, responsible for carrying bile from the liver to the gallbladder and small intestine for digestion, fail to develop normally.
​
The exact cause of biliary atresia is unknown. However, it typically presents in the neonatal period with persistent jaundice, clay-colored stools, and hepatomegaly (enlarged liver). If left untreated, the condition is fatal, with a reported survival rate of less than 10% at 3 years of age.​
Please join us on for a lively discussion with experts about new developments in treating Biliary Atresia.
Alagille Syndrome
(ALGS)
WEBINAR:
AUG 21, 2025
5:30pm to 6:30pm PDT
Alagille Syndrome or ALGS is a rare genetic disease that affects liver, heart, spine, eye, face, kidneys, and blood vessels. This disease is caused by changes (mutations) in a gene called "JAGGED1.” Most patients with ALGS have liver disease caused by "bile duct paucity," which means a decrease in the number of bile ducts in the liver.
​
Most patients with ALGS are unable to absorb enough fat and the fat-soluble vitamins (A, D, E and K) due to inadequate levels of bile salts getting into the intestine. This leads to poor growth and malnutrition.
​
To learn about this rare disease join us on August 21st from 5:30 to 6:30 pm for an informative discussion with experts about ALGS.
PRIMARY BILIARY
CHOLANGITIS (PBC)
WEBINAR:
SEPT 10, 2025
5:30pm to 6:30pm PDT
Primary biliary cholangitis (PBC) is an autoimmune disease in which the bile ducts are inflamed and slowly destroyed. Bile is a fluid made in the liver. It helps with digestion and absorbing certain vitamins. It also helps the body absorb fats and get rid of cholesterol, toxins and worn-out red blood cells. Ongoing inflammation in the liver can lead to bile duct inflammation and damage known as cholangitis. At times, this can lead to permanent scarring of liver tissue, called cirrhosis. It also can eventually lead to liver failure.
We invite you to join us on September 10, 2025 for a comprehensive discussion on PBC with our local experts.
What Is Alagille Syndrome
(ALGS)
WEBINAR:
FEB 13, 2025
5:30pm to 6:30pm PDT
Alagille syndrome (ALGS) is a condition affecting the liver, heart, spine, eye, face, kidneys, and blood vessels that is caused by changes (mutations) in a gene called "JAGGED1.” ALGS is a rare condition. Most patients with ALGS have liver disease caused by "bile duct paucity," which means a decrease in the number of bile ducts in the liver. It is now recognized that ALGS is caused by abnormal development of many organs. In some patients, the heart problems caused by ALGS are much more important than liver disease.
Infants with ALGS may show jaundice (a yellowish tinge in the eyes and skin), pale or loose stools, poor growth, and may have problems breathing or have pale or dusky skin color (if a heart problem is serious). Most patients with ALGS show signs and symptoms of liver problems at birth or soon after.
To learn more, please join us for this free webinar where our experts will discuss this disease and review the latest in ALGS treatments.